These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38995531)
1. Blockade of PD-1 and TIM-3 Ameliorates CD8 Jin T; Gao F; Wang L Cell Biochem Biophys; 2024 Sep; 82(3):2759-2766. PubMed ID: 38995531 [TBL] [Abstract][Full Text] [Related]
2. The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy. Decroos A; Meddour S; Demoy M; Piccirilli N; Rousselot P; Nicolini FE; Ragot S; Gombert JM; Herbelin A; Barbarin A; Cayssials E Front Immunol; 2024; 15():1473139. PubMed ID: 39620210 [TBL] [Abstract][Full Text] [Related]
3. Myeloid-Derived Suppressor Cells Induce Exhaustion-Like CD8 Zhang W; Yu Q; Gao X; Chen H; Su J; Chen Y; Li Y; Zhang N; Fu Z; Cui M Int J Biol Sci; 2024; 20(15):5959-5978. PubMed ID: 39664572 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity. He N; Li G; Liu J; Liu W; Tian R; Ma D Front Immunol; 2024; 15():1452035. PubMed ID: 39635534 [TBL] [Abstract][Full Text] [Related]
5. Development, Function, and Clinical Significance of Plasmacytoid Dendritic Cells in Chronic Myeloid Leukemia. Inselmann S; Wang Y; Saussele S; Fritz L; Schütz C; Huber M; Liebler S; Ernst T; Cai D; Botschek S; Brendel C; Calogero RA; Pavlinic D; Benes V; Liu ET; Neubauer A; Hochhaus A; Burchert A Cancer Res; 2018 Nov; 78(21):6223-6234. PubMed ID: 30166420 [TBL] [Abstract][Full Text] [Related]
6. Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors. Haoyue W; Kexiang S; Shan TW; Jiamin G; Luyun Y; Junkai W; Wanli D Phytomedicine; 2024 Nov; 136():156224. PubMed ID: 39642461 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of CD244 promotes CD8 Wang M; Deng B; Jiang T; Duolikun A; Li Y; Ainiwaer A; Kang X; Zheng X; Rousu Z; Yu Q; Li J; Wang H; Zhang C; Aji T; Shao Y Parasit Vectors; 2024 Nov; 17(1):483. PubMed ID: 39578914 [TBL] [Abstract][Full Text] [Related]
8. [Preparation of a dual-specific antibody targeting human CD123 and exploration of its anti-acute myeloid leukemia effects]. Zhou T; Chen ML; Zhang CY; Liu XY; Wang ZZ; Xing HY; Tang KJ; Tian Z; Rao Q; Wang M; Wang JX Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):225-232. PubMed ID: 38716593 [No Abstract] [Full Text] [Related]
9. Euphorbia Pekinensis Rupr. sensitizes colorectal cancer to PD-1 blockade by remodeling the tumor microenvironment and enhancing peripheral immunity. Chen YY; Zeng XT; Gong ZC; Zhang MM; Wang KQ; Tang YP; Huang ZH Phytomedicine; 2024 Dec; 135():156107. PubMed ID: 39368338 [TBL] [Abstract][Full Text] [Related]
10. Differential predictive value of resident memory CD8 Paolini L; Tran T; Corgnac S; Villemin JP; Wislez M; Arrondeau J; Johannes L; Ulmer J; Vieillard LV; Pineau J; Gey A; Quiniou V; Barennes P; Pham HP; Gruel N; Hasan M; Libri V; Mella S; De Percin S; Boudou-Rouquette P; Caidi A; Cremer I; Blons H; Leroy K; Laurent-Puig P; De Saint Basile H; Gibault L; Ravel P; Mami-Chouaib F; Goldwasser F; Fabre E; Damotte D; Tartour E J Immunother Cancer; 2024 Dec; 12(12):. PubMed ID: 39631852 [TBL] [Abstract][Full Text] [Related]
11. B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies. Lee S; Chae SJ; Jang IH; Oh SC; Kim SM; Lee SY; Kim JH; Ko J; Kim HJ; Song IC; Kim JK; Kim TD EBioMedicine; 2024 Dec; 110():105459. PubMed ID: 39579618 [TBL] [Abstract][Full Text] [Related]
12. Liposomal honokiol inhibits non-small cell lung cancer progression and enhances PD-1 blockade via suppressing M2 macrophages polarization. Cheng Y; Han X; Lai X; Wei X Phytomedicine; 2024 Dec; 135():156093. PubMed ID: 39531934 [TBL] [Abstract][Full Text] [Related]
13. Euphorbia helioscopia L. inhibits lung tumorigenesis through alleviating exhausted T cell induced by chronic inflammation. Duan W; Zhou Z; Huang Y; Cui Y; Jin X; Liu R; Chen L J Ethnopharmacol; 2025 Feb; 338(Pt 2):119097. PubMed ID: 39537116 [TBL] [Abstract][Full Text] [Related]
14. Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial. Short NJ; Nguyen D; Jabbour E; Senapati J; Zeng Z; Issa GC; Abbas H; Nasnas C; Qiao W; Huang X; Borthakur G; Chien K; Haddad FG; Pemmaraju N; Karrar OS; Nguyen D; Konopleva M; Kantarjian H; Ravandi F Lancet Haematol; 2024 Nov; 11(11):e839-e849. PubMed ID: 39303729 [TBL] [Abstract][Full Text] [Related]
15. [Exploration of key ferroptosis-related genes as therapeutic targets for sepsis based on bioinformatics and the depiction of their immune profiles characterization]. Li M; Mei Y; Pan A Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Oct; 36(10):1025-1032. PubMed ID: 39586719 [TBL] [Abstract][Full Text] [Related]
16. [Construction of CD138-targeted chimeric antigen receptor- modified T cells and their effect in multiple myeloma therapy]. Guo CC; Lu Y; Tang KJ; Xing HY; Tian Z; Rao Q; Wang M; Xiong DS; Wang JX Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):436-444. PubMed ID: 38964917 [No Abstract] [Full Text] [Related]
17. BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph Peter B; Eisenwort G; Sadovnik I; Bauer K; Willmann M; Rülicke T; Berger D; Stefanzl G; Greiner G; Hoermann G; Keller A; Wolf D; Čulen M; Winter GE; Hoffmann T; Schiefer AI; Sperr WR; Zuber J; Mayer J; Valent P Am J Hematol; 2022 Sep; 97(9):1215-1225. PubMed ID: 35794848 [TBL] [Abstract][Full Text] [Related]
18. PD-1/PD-L1 governed cross-talk of exhausted CD8 Wang K; Zhao J; Feng X; He S; Li J; Sun F; Xu Z; Yang H; Ye J; Cao L; Ye S RMD Open; 2024 Jan; 10(1):. PubMed ID: 38233074 [TBL] [Abstract][Full Text] [Related]
19. PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors. Gill AL; Wang PH; Lee J; Hudson WH; Ando S; Araki K; Hu Y; Wieland A; Im S; Gavora A; Medina CB; Freeman GJ; Hashimoto M; Reiner SL; Ahmed R Sci Immunol; 2023 Aug; 8(86):eadg0539. PubMed ID: 37624909 [TBL] [Abstract][Full Text] [Related]
20. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]